[go: up one dir, main page]

WO2008111503A1 - 移植臓器保護剤 - Google Patents

移植臓器保護剤 Download PDF

Info

Publication number
WO2008111503A1
WO2008111503A1 PCT/JP2008/054133 JP2008054133W WO2008111503A1 WO 2008111503 A1 WO2008111503 A1 WO 2008111503A1 JP 2008054133 W JP2008054133 W JP 2008054133W WO 2008111503 A1 WO2008111503 A1 WO 2008111503A1
Authority
WO
WIPO (PCT)
Prior art keywords
transplanted organ
protective agent
composition
transplanted
organ
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2008/054133
Other languages
English (en)
French (fr)
Inventor
Hiroshi Suzuki
Hideki Saito
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Obihiro University of Agriculture and Veterinary Medicine NUC
Original Assignee
Chugai Pharmaceutical Co Ltd
Obihiro University of Agriculture and Veterinary Medicine NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd, Obihiro University of Agriculture and Veterinary Medicine NUC filed Critical Chugai Pharmaceutical Co Ltd
Priority to EP08721551A priority Critical patent/EP2143439A4/en
Priority to US12/530,491 priority patent/US20100137191A1/en
Priority to JP2009504020A priority patent/JP5763882B2/ja
Priority to CA002680236A priority patent/CA2680236A1/en
Publication of WO2008111503A1 publication Critical patent/WO2008111503A1/ja
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Surgery (AREA)
  • Toxicology (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

　エリスロポエチン（EPO）を有効成分とする移植臓器保護用組成物、移植臓器の生着促進用組成物、若しくは移植臓器保存用組成物。
PCT/JP2008/054133 2007-03-09 2008-03-07 移植臓器保護剤 Ceased WO2008111503A1 (ja)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP08721551A EP2143439A4 (en) 2007-03-09 2008-03-07 MEANS FOR THE PROTECTION OF A TRANSPLANTED ORGAN
US12/530,491 US20100137191A1 (en) 2007-03-09 2008-03-07 Protective agents for transplanted organs
JP2009504020A JP5763882B2 (ja) 2007-03-09 2008-03-07 移植臓器保護剤
CA002680236A CA2680236A1 (en) 2007-03-09 2008-03-07 Protective agents for transplanted organs

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007-059632 2007-03-09
JP2007059632 2007-03-09

Publications (1)

Publication Number Publication Date
WO2008111503A1 true WO2008111503A1 (ja) 2008-09-18

Family

ID=39759442

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/054133 Ceased WO2008111503A1 (ja) 2007-03-09 2008-03-07 移植臓器保護剤

Country Status (10)

Country Link
US (1) US20100137191A1 (ja)
EP (1) EP2143439A4 (ja)
JP (1) JP5763882B2 (ja)
CN (1) CN101631561A (ja)
AR (1) AR065613A1 (ja)
CA (1) CA2680236A1 (ja)
CL (1) CL2008000701A1 (ja)
PE (1) PE20081879A1 (ja)
TW (1) TW200904825A (ja)
WO (1) WO2008111503A1 (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2631915T3 (es) 2008-09-26 2017-09-06 Ambrx, Inc. Polipéptidos modificados de eritropoyetina animal y sus usos
NL2010225C2 (en) * 2013-02-01 2014-08-04 Conradus Ghosal Gho Composition and method for preserving, transporting and storing living biological materials.
CN116492448A (zh) * 2023-04-12 2023-07-28 深圳赛保尔生物药业有限公司 负载peg-epo及间充质干细胞的组合物、药物及其制备方法

Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985002610A1 (en) 1983-12-13 1985-06-20 Kirin-Amgen, Inc. Production of erythropoietin
WO1990012874A2 (en) 1989-04-21 1990-11-01 Genetics Institute, Inc. Cysteine added variants of polypeptides and chemical modifications thereof
WO1991005867A1 (en) 1989-10-13 1991-05-02 Amgen Inc. Erythropoietin isoforms
WO1995005465A1 (en) 1993-08-17 1995-02-23 Amgen Inc. Erythropoietin analogs
JPH10182481A (ja) 1996-04-26 1998-07-07 Chugai Pharmaceut Co Ltd エリスロポエチン溶液製剤
JP2003225084A (ja) * 2000-12-28 2003-08-12 Japan Science & Technology Corp 凍結細胞保存剤
WO2004022545A1 (ja) 2002-09-06 2004-03-18 Mitsubishi Pharma Corporation 移植臓器保護剤
WO2004099363A2 (en) * 2003-05-01 2004-11-18 Medgenics Inc. Dermal micro organs, methods and apparatuses for producing and using the same
JP2005507426A (ja) 2001-10-29 2005-03-17 クルセル ホランド ベー ヴェー 所定の翻訳後修飾を有する蛋白質の製造方法及び製造手段
WO2005063965A1 (de) * 2003-12-30 2005-07-14 Bionethos Holding Gmbh Verfahren zur regeneration von gewebe
JP2005350364A (ja) 2004-06-08 2005-12-22 Kyorin Pharmaceut Co Ltd ヘムオキシゲナーゼの誘導または誘導促進剤としてのプロリン誘導体
JP2005350363A (ja) 2004-06-08 2005-12-22 Kyorin Pharmaceut Co Ltd ヘムオキシゲナーゼの誘導または誘導促進剤としての４−トリフルオロメチルピリミジン誘導体
WO2006002646A2 (en) * 2004-07-07 2006-01-12 H. Lundbeck A/S Novel carbamylated epo and method for its production

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7767643B2 (en) * 2000-12-29 2010-08-03 The Kenneth S. Warren Institute, Inc. Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs
US6531121B2 (en) * 2000-12-29 2003-03-11 The Kenneth S. Warren Institute, Inc. Protection and enhancement of erythropoietin-responsive cells, tissues and organs
PA8536201A1 (es) * 2000-12-29 2002-08-29 Kenneth S Warren Inst Inc Protección y mejoramiento de células, tejidos y órganos que responden a la eritropoyetina
US7468242B2 (en) * 2001-11-05 2008-12-23 Medgenics, Inc. Dermal micro organs, methods and apparatuses for producing and using the same
DE10234192B4 (de) * 2002-07-26 2009-11-26 Epoplus Gmbh Co.Kg Verwendung von Erythropoetin
US7459152B2 (en) * 2003-04-23 2008-12-02 Rush University Medical Center Erythropoietin administration to improve graft survival

Patent Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985002610A1 (en) 1983-12-13 1985-06-20 Kirin-Amgen, Inc. Production of erythropoietin
WO1990012874A2 (en) 1989-04-21 1990-11-01 Genetics Institute, Inc. Cysteine added variants of polypeptides and chemical modifications thereof
WO1991005867A1 (en) 1989-10-13 1991-05-02 Amgen Inc. Erythropoietin isoforms
EP0428267A2 (en) 1989-10-13 1991-05-22 Amgen Inc. Erythropoietin isoforms
WO1995005465A1 (en) 1993-08-17 1995-02-23 Amgen Inc. Erythropoietin analogs
JPH10182481A (ja) 1996-04-26 1998-07-07 Chugai Pharmaceut Co Ltd エリスロポエチン溶液製剤
JP2003225084A (ja) * 2000-12-28 2003-08-12 Japan Science & Technology Corp 凍結細胞保存剤
JP2005507426A (ja) 2001-10-29 2005-03-17 クルセル ホランド ベー ヴェー 所定の翻訳後修飾を有する蛋白質の製造方法及び製造手段
WO2004022545A1 (ja) 2002-09-06 2004-03-18 Mitsubishi Pharma Corporation 移植臓器保護剤
WO2004099363A2 (en) * 2003-05-01 2004-11-18 Medgenics Inc. Dermal micro organs, methods and apparatuses for producing and using the same
WO2005063965A1 (de) * 2003-12-30 2005-07-14 Bionethos Holding Gmbh Verfahren zur regeneration von gewebe
JP2005350364A (ja) 2004-06-08 2005-12-22 Kyorin Pharmaceut Co Ltd ヘムオキシゲナーゼの誘導または誘導促進剤としてのプロリン誘導体
JP2005350363A (ja) 2004-06-08 2005-12-22 Kyorin Pharmaceut Co Ltd ヘムオキシゲナーゼの誘導または誘導促進剤としての４−トリフルオロメチルピリミジン誘導体
WO2006002646A2 (en) * 2004-07-07 2006-01-12 H. Lundbeck A/S Novel carbamylated epo and method for its production

Non-Patent Citations (20)

* Cited by examiner, † Cited by third party
Title
DALBADIE-MCFARLAND, G. ET AL., PROC. NATL. ACAD. SCI. USA, vol. 79, 1982, pages 6409 - 6413
GOTOH, T. ET AL., GENE, vol. 152, 1995, pages 271 - 275
IAMI N. ET AL.: "PHYSICOCHEMICAL AND BIOLOGICAL CHARACTERIZATION OF ASIALOERYTHROPOIETIN", EUR. J. BIOCHEM., vol. 194, no. 2, 1990, pages 457 - 462, XP000669631 *
ISHIJIMA T ET AL., J REPROD DEV., vol. 52, no. 2, April 2006 (2006-04-01), pages 293 - 9
KENNETH JACOBS ET AL., NATURE, vol. 313, 1985, pages 806 - 810
KRAMER, W. ET AL., NUCLEIC ACIDS RES., vol. 12, 1984, pages 9441 - 9456
KRAMER, W.; FRITZ, H.J., METHODS ENZYMOL., vol. 154, 1987, pages 350 - 367
KUNKEL, METHODS ENZYMOL., vol. 85, 1988, pages 2763 - 2766
KUNKEL, T.A., PROC. NATL. ACAD. SCI. USA., vol. 82, 1985, pages 488 - 492
MARK, D.F. ET AL., PROC. NATL. ACAD. SCI. USA, vol. 81, 1984, pages 5662 - 5666
MIGISHIMA F ET AL., BIOL REPROD, vol. 68, no. 3, March 2003 (2003-03-01), pages 881 - 7
NOBUO IMAI ET AL., EUR. J. BIOCHEM, vol. 194, 1990, pages 457 - 462
OKTAY K ET AL., BIOL REPROD., vol. 53, no. 2, August 1995 (1995-08-01), pages 295 - 301
PANS, vol. 100, 2003, pages 4802 - 4806
PNAS, vol. 100, 2003, pages 4802 - 4806
PNAS, vol. 101, 2004, pages 14907 - 14912
See also references of EP2143439A4
WANG, A. ET AL., SCIENCE, vol. 224, pages 1431 - 1433
ZOLLER, M.J.; SMITH, M., METHODS ENZYMOL., vol. 100, 1983, pages 468 - 500
ZOLLER, M.J.; SMITH, M., NUCLEIC ACIDS RESEARCH, vol. 10, 1982, pages 6487 - 6500

Also Published As

Publication number Publication date
TW200904825A (en) 2009-02-01
JPWO2008111503A1 (ja) 2010-06-24
US20100137191A1 (en) 2010-06-03
EP2143439A1 (en) 2010-01-13
EP2143439A4 (en) 2011-06-29
CA2680236A1 (en) 2008-09-18
AR065613A1 (es) 2009-06-17
JP5763882B2 (ja) 2015-08-12
PE20081879A1 (es) 2009-01-10
CL2008000701A1 (es) 2008-09-12
CN101631561A (zh) 2010-01-20

Similar Documents

Publication Publication Date Title
WO2007067044A3 (en) Modified active-ingredient-containing pellets/capsules
WO2009039951A3 (de) Wirkstoffkombinationen mit insektiziden und akariziden eigenschaften
WO2008134744A3 (en) Pesticidal compositions
WO2008146174A3 (en) Use of compounds having a monogalactosyldiacylglycerol synthase inhibitory activity as herbicide or algaecide, herbicide and algaecide compositions
WO2009082134A3 (en) Dipeptidyl peptidase-iv inhibiting compounds, methods of preparing the same, and pharmaceutical compositions containing the same as active agent
UA101346C2 (ru) 4-фенилпиран-3,5-дионы, 4-фенилтиопиран-3,5-дионы и 2-фенилциклогексан-1,3,5-трионы как гербициды
WO2010032135A3 (en) Spinosyn antifouling compositions, methods of use thereof and articles protected from attachment of biofouling organisms
EP2023724B8 (de) Synergistische wirkstoffkombinationen
WO2007030361A3 (en) Benzimidazole thiophene compounds as plk inhibitors
WO2009105969A8 (zh) 埃坡霉素类似物、其药物组合物、用途及其制备方法
WO2011039444A3 (fr) Composition, utilisation et procédé de conservation
WO2011151247A3 (en) Pesticidal compositions
WO2010083955A3 (de) Verwendung von enaminocarbonylverbindungen zur bekämpfung von durch insekten übertragenen virosen
SI1864666T1 (sl) Zaščitno sredstvo za retinalno nevronsko celico, vsebujoče derivat prostaglandina F2 alfa kot učinkovino
WO2010066677A3 (de) Herbizide mischungen enthaltend thaxtomin- derivate und protoporphyrinogen- ix- oxidase- inhibitoren
WO2010046215A3 (en) Diaza-indole derivatives and their use as fungicides
WO2009000533A8 (en) Novel herbicides
WO2011067209A3 (en) Pesticidal mixtures
WO2011064533A3 (en) Compositions containing a 3 - phenyluracil herbicide and a sulfamoylphenylurea safener
WO2009103813A3 (de) Fungizide zusammensetzungen mit 3'-brom-2,3,4,6'-tetramethoxy-2'-6-dimethylbenzophenon
WO2008111503A1 (ja) 移植臓器保護剤
WO2010138420A3 (en) Glutaraldehyde based biocidal compositions and methods of use
WO2010149309A3 (de) Cycloalkylamidbenzoxa(thia)zole als fungizide
WO2010149283A3 (de) Phenyloxy(thio)phenylamidbenzoxa(thia)zole
WO2008070354A3 (en) 5- and 6- substituted benzimidazole thiophene compounds

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200880007755.7

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08721551

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2009504020

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2680236

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 5908/CHENP/2009

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 2008721551

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 12530491

Country of ref document: US